Patents Assigned to Mellitus, LLC
  • Anti-CD59 antibodies
    Patent number: 11866506
    Abstract: Anti-CD59 and anti-glycated CD59 antibodies are disclosed. Assays, diagnostics, kits, and assay components including such antibodies are provided. Methods for the assessment of diabetes-related indications are included as well as inhibitors of CD59 glycation and methods of evaluating such inhibitors.
    Type: Grant
    Filed: April 17, 2018
    Date of Patent: January 9, 2024
    Assignee: Mellitus, LLC
    Inventors: Michael Chorev, Jose A. Halperin